In this study, we finally analyzed three resistin SNPs (rs1862513, rs3745368, and rs3745367) in 278 RA patients and 276 normal controls recruited from Chinese population using TaqMan SNP genotyping assays.
| INTRODUC TI ON
Rheumatoid arthritis (RA) is a systemic autoimmune disorder, characterized by chronic inflammation of the joints which may arouse enormous inflammation in the synovium, and the permanent destruction to joint cartilage and bone. 1 Although, the incidence of RA is approximately 1% in the world, the precise mechanism of this disease is still unclear. As the exciting discovery of the precise properties of adipokines, the associations between adipokines and RA and the understanding of the potential mechanism have attracted attention. Adipokines are predominantly secreted by white adipose tissue, which is known as a primary endocrine organ in humans. 2 Moreover, stimulated articular adipose tissue would highly produce classical adipokines and a wide range of pro-inflammatory and anti-inflammatory cytokines. 3 Studies have demonstrated that adipokines, which have the function to modulate various processes including inflammatory and metabolism, might be involved in the pathophysiology of obesity-related diseases including RA. [4] [5] [6] Increased adipokine levels were also found in the plasma and synovial fluid from RA patients, and the results implied that adipokines were involved in the pathogenesis of RA by exerting effective modulatory effects on target tissues and cells including cartilage, synovium, bone, and various immune cells. 7, 8 Resistin (resistance to insulin) is initially found to be produced by murine adipocytes and could improve insulin resistance. 9 Moreover, inflammatory cytokines are shown to induce resistin synthesis in human monocytes. 10 Because of the ability of resistin to the activate NF-κB-dependent pathways to secrete tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and IL-1β in human peripheral blood mononuclear cells, and increase MAPK activation, 11, 12 resistin is perceived as a pro-inflammatory cytokine and might instead be involved in inflammatory processes rather than in the modulation of glucose homeostasis in humans. 5 Previous evidences suggested that resistin level in plasma was correlated strongly with several inflammatory markers including C reactive protein (CRP), IL-6. 13 In RA patients, resistin was found increased in the synovium when compared to these with osteoarthritis, and significantly associated with several inflammatory markers including CRP and erythrocyte sedimentation rate (ESR). 14 Furthermore, healthy mouse when injected recombinant resistin into knee joints was also shown to induce leukocyte infiltration and hyperplasia of the synovial, which was similar to the pathology of RA.
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These findings had shown that resistin might have a potential role in RA pathogenesis, and aberrant serum levels of resistin were found in RA sufferers, 15, 16 while few studies had discussed the relationship between resistin gene variation and RA risk. On this basis, we carried out this study to investigate whether resistin gene polymorphisms (rs1862513, rs3745368, and rs3745367) are connected with RA susceptibility in a Chinese population.
| S TUDY SUBJEC TS AND ME THODS

| RA patients and normal controls
In this study, we initially recruited 288 RA patients and 288 nor- 
| DNA extraction and SNP genotyping
Blood samples (5 mL) were collected from each subject, and genomic DNA was isolated from the peripheral blood leukocytes by the standard procedures with the Flexi Gene-DNA Kit (Qiagen, Valencia, CA). genotype success rate for all SNPs were included for analysis; thus, we finally analyzed the three resistin SNPs (rs1862513, rs3745368, and rs3745367) in 278 RA patients and 276 normal controls.
| Statistical analysis
The Hardy-Weinberg equilibrium for normal controls was assessed using chi-square (χ Above statistical analyses were performed using the SPSS 10.01
(SPSS Inc., IL, USA), and P value (two-sided) <.05 was considered as statistically significant. 
| RE SULTS
| The associations between resistin gene rs1862513, rs3745368, and rs3745367 polymorphisms and RA susceptibility
The genotype and allele frequencies of rs1862513, rs3745368, and rs3745367 in RA patients and normal controls were represented in Table 1 . There were no significant differences in genotype distributions of all SNPs polymorphism between RA patients and normal controls (all P > .05). Similarly, no significant findings regarding the allele frequencies of all SNPs were observed (all P > .05). In addition, the association of resistin gene variation with RA under two main genetic models including dominant, recessive models was also analyzed, and the results were still not significant (all P > .05).
| The associations of resistin gene rs1862513, rs3745368, and rs3745367 polymorphisms with risk of different serotypes of RA
We carried out a case-only study to evaluate the associations of resistin gene rs1862513, rs3745368, and rs3745367 polymorphisms and genetic susceptibility to different serotypes of RA patients, and the results were shown in Table 2 . However, the relationship of genetic heterogeneity between anti-CCP-positive and anti-CCPnegative RA patients was not statistically significant, as well as between RF-positive and RF-negative RA patients.
| Haplotype analysis
Six main haplotypes (CAG, CGG, GAA, GAG, GGA, and GGG) for resistin gene were determined by SHEsis software (Table 3) . We found that the frequency of haplotype GAA was dramatically lower in RA patients when contrasted to normal controls (OR = 0.317, 95% CI:
0.125-0.807, P = .011).
| D ISCUSS I ON
Rheumatoid arthritis is generally known as a chronic, complex autoimmune disease characterized by has complex genetic backgrounds. 19, 20 Several studies have shown that pro-inflammatory cytokines play critical roles in the pathogenesis of multiple autoimmune diseases, including RA and systemic lupus erythematosus (SLE). 21, 22 Recent investigations had indicated increased serum resistin level in RA patients when compared to the healthy controls. 15, 16 Nevertheless, results from these studies were inconsistent, and several studies had suggested that no significant difference was found in the serum expression level of resistin between RA patients and healthy controls. 23, 24 To further analyze serum resistin level in RA patients, a comprehensive meta-analysis was performed and the result indicated that serum resistin level in RA patients was significantly elevated. 25 In addition, the serum resistin levels were related to clinical disease activity, CRP and ESR in RA. 14, 15 Similarly, a significant correlation between synovial fluid resistin level and several inflammatory markers of RA was also found in another study. 26 Therefore, resistin might be contributed to the inflammatory process in RA act as a significant mediator.
Several inflammation-associated SNPs including rs1862513, rs3745368, and rs3745367 in resistin gene, which located on chromosome 19p13, have been reported to relate with resistin concentration in some studies. [27] [28] [29] [30] Therefore, we hypothesized that resistin gene polymorphisms might have a crucial role in RA development.
However, we failed to found any significant relationship between resistin gene polymorphisms and RA risk in the present study, while the haplotype GAA was considered to be a significant protective haplotype for RA. Indeed, recent study implied that obesity might modestly contribute to RA and was associated with low-grade chronic inflammation. 5 A recent meta-analysis revealed that resistin rs1862513 variant may be related to obesity. 31 In another study, the authors suggested that the G allele of the -852A>G and haplotypes with G alleles at -852 and -420 were associated with higher circulating inflammatory biomarkers. This implied that resistin gene polymorphisms might be associated with several inflammatory biomarkers secreted in serum/synovial from RA patients. 32 In addition, increasing evidences have shown that RA could be divided into disparate genetic subsets depend on the status of autoantibodies including anti-CCP and RF. 33, 34 We also analyzed the potential associations between resistin gene polymorphisms and disparate serotypes of RA.
Unfortunately, no significant associations were observed.
Several studies explored the role of resistin gene in cancer, diabetes, and autoimmune diseases had appeared in recent years. [35] [36] [37] [38] Alharithy et al indicated that resistin rs1862513 heterozygous (CG) genotype and rs3745367 heterozygous (GA) genotype were significantly associated with an increased risk of colon cancer. 35 However, a previous study showed that resistin polymorphisms at rs1862513 and rs3745367 were not significantly linked to the risk of lung cancer. 36 A study by Thammakun et al suggested that resistin polymorphism at position +62 G>A (rs3745368) might increase the susceptibility to type 2 diabetes mellitus in Thais. 37 Another study demonstrated that resistin rs1862513 polymorphism might be of some significance in multiple sclerosis patients due to significantly higher resistin level was detected in GG genotype of resistin rs1862513 compared with CC carriers. 38 Hence, resistin gene polymorphisms might be involved in the development of autoimmune diseases by affecting the secretion and activity of inflammatory cytokines.
In conclusion, the results revealed that the frequency of haplotype GAA was significantly lower in RA patients, and resistin 
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